Abstract:Human islet amyloid polypeptide (hIAPP or amylin) is a causative agent in pancreatic amyloid deposits found in patients with type 2 diabetes. The aggregation of full-length hIAPP(1-37) into small oligomeric species is increasingly believed to be responsible for cell dysfunction and death. However, rat IAPP (rIAPP(1-37)), which differs from hIAPP in only six of 37 residues, loses its aggregation ability to form toxic amyloid species. Atomic details of the effect of sequence on the structure and toxicity between the amyloidogenic, toxic hIAPP peptide and the nonamyloidogenic, nontoxic rIAPP peptide remain unclear. Here, we probe sequence-induced differences in structural stability, conformational dynamics, and driving forces between different hIAPP and rIAPP polymorphic forms from monomer to pentamer using molecular dynamics simulations. Simulations show that hIAPP forms from trimer to pentamer exhibit high structural stability with well-preserved in-register parallel beta-sheet and the U-bend conformation. The hIAPP trimer appears to be a smallest minimal seed in solution. The stabilities of parallel hIAPP oligomers increase with the number of peptides. Conversely, replacement of hIAPP sequence by rIAPP sequence causes a significant loss of favorable interpeptide interactions in all rIAPP oligomers, destabilizing the C-terminal beta-sheet, turn conformation, and overall stability. A less beta-sheet-rich structure and a disturbed U-shaped topology exert a large energy penalty on the self-assemble of the rIAPP peptides into highly ordered, in-register beta-sheet-rich protofibrils and fibrils, which explains the nonamyloidogenic activity of rIAPP. Moreover, the absence of interior water within the U-turn region in the well-packed higher-order hIAPP oligomers, not in the poorly packed rIAPP oligomers, also stabilizes peptide association. This work provides atomic details of the sequence-structure relationship between the amyloidogenic hIAPP and its analogues such as the nonamyloidogenic rIAPP and some mutants, which could help in the development of novel therapeutic agents to block the formation of toxic hIAPP oligomeric species for type 2 diabetes.

Computational insights into the inhibition and destabilization of morin on the oligomer of full-length human islet amyloid polypeptide.

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.

Molecular Dynamics Simulation on the Inhibition Mechanism of Peptide-Based Inhibitor of Islet Amyloid Polypeptide (iapp) to Islet Amyloid Polypeptide (Iapp(22-28)) Oligomers

Insights into the mechanism of how Morin suppresses amyloid fibrillation of hen egg white lysozyme

Mechanism Study on the Abnormal Accumulation and Deposition of Islet Amyloid Polypeptide by Cold-Spray Ionization Mass Spectrometry.

Inhibitory Mechanism of Morin on Α-Glucosidase and Its Anti-Glycation Properties.

The inhibitory effect of hydroxylated carbon nanotubes on the aggregation of human islet amyloid polypeptide revealed by a combined computational and experimental study.

Conformation-Dependent Manipulation of Human Islet Amyloid Polypeptide Fibrillation by Shiitake-Derived Lentinan.

Exploration of Isoquinoline Alkaloids As Potential Inhibitors Against Human Islet Amyloid Polypeptide

Triterpenoids impede the fibrillation and cytotoxicity of human islet amyloid polypeptide

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Molecular Dynamics Simulations Reveal The Inhibitory Mechanism Of Dopamine Against Human Islet Amyloid Polypeptide (Hiapp) Aggregation And Its Destabilization Effect On Hiapp Protofibrils

Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.

The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide*

Recent computational studies of membrane interaction and disruption of human islet amyloid polypeptide: Monomers, oligomers and protofibrils

Molecular Mechanism of the Inhibition and Remodeling of Human Islet Amyloid Polypeptide (Hiapp(1-37)) Oligomer by Resveratrol from Molecular Dynamics Simulation.

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against Hiapp Aggregation Via Computational Simulations

Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide.

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Melatonin Inhibits hIAPP Oligomerization by Preventing β-Sheet and Hydrogen Bond Formation of the Amyloidogenic Region Revealed by Replica-Exchange Molecular Dynamics Simulation